BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $10.0B | +0.3% | −6.0% | −0.8% |
| Revenue (TTM) | $10.0B |
|---|---|
| YoY | +0.3% |
| 5-year CAGR | −6.0% |
| 10-year CAGR | −0.8% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $9.9B | +2.2% |
| 2024 | $9.7B | −1.6% |
| 2023 | $9.8B | −3.3% |
| 2022 | $10.2B | −7.4% |
| 2021 | $11.0B | −18.3% |
| 2020 | $13.4B | −6.5% |
| 2019 | $14.4B | +6.9% |
| 2018 | $13.5B | +9.6% |
| 2017 | $12.3B | +7.2% |
| 2016 | $11.4B | +6.4% |
| 2015 | $10.8B | +10.9% |
| 2014 | $9.7B | +40.0% |
| 2013 | $6.9B | +25.7% |
| 2012 | $5.5B | +9.3% |
| 2011 | $5.0B | +7.0% |
| 2010 | $4.7B | +7.7% |
| 2009 | $4.4B | +6.8% |
| 2008 | $4.1B | +29.2% |
| 2007 | $3.2B | — |